Skip to Content

InfuSystems Holdings Inc INFU

Morningstar Rating
$8.57 −0.23 (2.61%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

INFU is trading at a 12% discount.
Price
$8.72
Fair Value
$4.39
Uncertainty
Very High
1-Star Price
$16.59
5-Star Price
$8.49
Economic Moat
Zpz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INFU is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$8.80
Day Range
$8.558.85
52-Week Range
$7.4511.44
Bid/Ask
$8.57 / $9.44
Market Cap
$181.66 Mil
Volume/Avg
44,560 / 45,222

Key Statistics

Price/Earnings (Normalized)
106.21
Price/Sales
1.60
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
1.02%

Company Profile

InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
438

Comparables

Valuation

Metric
INFU
LUNG
OM
Price/Earnings (Normalized)
106.21
Price/Book Value
3.622.970.90
Price/Sales
1.605.040.84
Price/Cash Flow
11.86
Price/Earnings
INFU
LUNG
OM

Financial Strength

Metric
INFU
LUNG
OM
Quick Ratio
1.375.624.27
Current Ratio
2.086.505.26
Interest Coverage
1.80−19.37−13.39
Quick Ratio
INFU
LUNG
OM

Profitability

Metric
INFU
LUNG
OM
Return on Assets (Normalized)
2.71%−22.61%−39.03%
Return on Equity (Normalized)
5.59%−31.80%−72.89%
Return on Invested Capital (Normalized)
5.03%−25.75%−44.98%
Return on Assets
INFU
LUNG
OM
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncHyvwspktskCtbx$141.8 Bil
BDX
Becton Dickinson & CoVhbkcfdLgwzlk$71.2 Bil
ALC
Alcon IncSzdydgfCdwxj$41.1 Bil
CLPBY
Coloplast A/S ADRWhgrchvkvZhch$30.4 Bil
RMD
ResMed IncDwxdqjvyBltyz$28.9 Bil
WST
West Pharmaceutical Services IncBsqgxnprpkTvnc$28.9 Bil
BAX
Baxter International IncJkcbjjmcxDjvfxw$21.7 Bil
COO
The Cooper Companies IncCzsqjymyjQtxdsv$20.2 Bil
HOLX
Hologic IncLbgryscvPjymqm$18.2 Bil
TFX
Teleflex IncHwphYwczd$10.5 Bil

Sponsor Center